Covered recipient · General Payments record
JENNIE H LAW
Allopathic & Osteopathic Physicians Internal Medicine Endocrinology, Diabetes & Metabolism
General Payments · PY2023–2024
$459.56
- Reported across 22 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $363.09 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $69.56 | 3 |
| Inspire Medical Systems, Inc. | $60.78 | 1 |
| ABBVIE INC. | $45.03 | 3 |
| Amgen Inc. | $42.18 | 2 |
| Astellas Pharma US Inc | $40.35 | 2 |
| Corcept Therapeutics | $33.41 | 2 |
| Exact Sciences Corporation | $20.75 | 1 |
| CeQur Corporation | $18.32 | 1 |
| Lilly USA, LLC | $18.11 | 1 |
| Acerta Pharma LLC | $14.60 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $13.19 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104143576 | CMS |
| ABBVIE INC. | $14.34 | 05/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104143578 | CMS |
| ABBVIE INC. | $17.50 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104143580 | CMS |
| Amgen Inc. | $23.78 | 07/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111629650 | CMS |
| Amgen Inc. | $18.40 | 08/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111629648 | CMS |
| Astellas Pharma US Inc | $18.33 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139308576 | CMS |
| Astellas Pharma US Inc | $22.02 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139416003 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.60 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104523106 | CMS |
| CeQur Corporation | $18.32 | 04/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1126845282 | CMS |
| Corcept Therapeutics | $15.19 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117786759 | CMS |
| Corcept Therapeutics | $18.22 | 02/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117786783 | CMS |
| Exact Sciences Corporation | $20.75 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114750233 | CMS |
| Inspire Medical Systems, Inc. | $60.78 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148072302 | CMS |
| Lilly USA, LLC | $18.11 | 02/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135040207 | CMS |
| Novo Nordisk Inc | $21.13 | 01/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097139446 | CMS |
| Novo Nordisk Inc | $20.01 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097347939 | CMS |
| Novo Nordisk Inc | $28.42 | 09/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097620804 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023, 2024
- Source files
- Dataset page · Bulk file · PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.